The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation-Reference-Cited by-同舟云学术

The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation

Published:2023-10 Issue:4 Volume:62 Page:106939
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Jin Yutong^ORCID,Benkeser David^ORCID,Kipiani Maia,Maranchick Nicole F.,Mikiashvili Lali^ORCID,Barbakadze Ketevan,Avaliani Zaza,Alghamdi Wael A.^ORCID,Alshaer Mohammad H.^ORCID,Peloquin Charles A.^ORCID,Blumberg Henry M,Kempker Russell R.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference33 articles.

1. Bedaquiline-pretomanid-linezolid regimens for drug-resistant tuberculosis;Conradie;N Engl J Med,2022

2. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis;Dorman;N Engl J Med,2021

3. New developments in tuberculosis diagnosis and treatment;Gill;Breathe (Sheff),2022

4. Rapid communication: key changes to the treatment of drug-resistant tuberculosis,2022

5. QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment;Monedero-Recuero;Int J Tuberc Lung Dis,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of therapeutic drug monitoring in the treatment of multi-drug resistant tuberculosis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-08

2. Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-01-25